Looking to launch 6-7 products over next 2-3 yrs: GSK Pharma

After recently closing a vaccines deal with Novartis, the Indian listed arm of British pharma giant GSK is now working on building an aggressive pipeline. Speaking exclusively to CNBC-TV18's Priya Sheth, Andrew Aristidou, CFO and ED Finance, GSK Pharma, said the company is looking to launch 6 to 7 new products over the next 2-3 years.On whether GSK would be looking to delist from India, Aristidou said the company's listed status is a "contribution of an MNC being a local company" here and added that the delisting process is anyway expensive here.Watch video for more…